Langerhans Cells and Nerves: Bidirectional Signaling
Langerhans Cells and Nerves: Bidirectional Signaling
批准号:
6918410
负责人:
RICHARD David GRANSTEIN
金额:
$36.96万
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-02-01 至 2010-05-31
关键词:
Langerhans&apos cellantibody formationantigen presentationcalcitonin gene related peptidecell migrationcontact dermatitiscytokinedenervationdevelopmental immunologyhelper T lymphocyteimmune responseintracellular transportlaboratory mouseneural transmissionneuroimmunomodulationneuropeptidesnorepinephrinepsychoneuroimmunologyvasoactive intestinal peptide
中文摘要
描述(由申请人提供):有大量证据表明压力、情绪状态和神经活动调节免疫反应。然而,除了内分泌作用外,这种调节的机制在细胞和分子水平上仍然不清楚。一个可以建立机械联系的系统是皮肤免疫系统。在皮肤中,朗格汉斯细胞(LCs)是表皮的抗原呈递细胞,受神经支配。此外,我们的实验室之前已经确定去甲肾上腺素(NE)、肾上腺素(EPI)和三种神经肽[降钙素基因相关肽(CGRP)、垂体腺苷酸激活肽(PACAP)和血管活性肠肽(VIP)]在体内和体外都能够调节皮肤免疫反应。这种神经-免疫相互作用可能在(a)某些病理状况(特应性皮炎、牛皮癣、自身免疫性疾病)、(b)对入侵病原体的正常反应和(c)疫苗接种期间对抗原的反应中很重要。然而,在理解这些途径方面仍有很大的差距。目前尚不清楚哪些细胞内信号通路负责介导神经递质的作用,或者不同的神经递质是否影响不同的通路。尽管神经影响Th1反应,但尚不清楚它们是否影响Th2反应或Th1与Th2反应的平衡。我们在此提出验证神经递质通过调节细胞内信号通路来调节Th1-和th2依赖性免疫反应的假设,特别是camp依赖性抑制NFkappaB的激活。与此相关的假设是,神经系统可能在选择发生的免疫反应类型方面发挥作用。目标1 -识别和研究介导NE/EPI、PACAP、VIP和CGRP对LCs成熟影响的细胞内信号事件。目的2 -确定神经肽或神经递质是否调节Th2反应、Th1/Th2细胞因子平衡和/或抗体产生。目的3 -确定去神经支配是否影响LCs的数量、成熟状态或诱导接触性超敏反应的能力。通过进一步探索由神经系统调节的皮肤免疫反应的类型,并通过确定这种调节的分子机制,我们将创造合理设计药物以改变病理和正常皮肤免疫反应所需的知识。皮肤的免疫反应。
英文摘要
DESCRIPTION (provided by applicant): There is substantial evidence that stress, emotional status and neural activity modulate immunological responsiveness. However, except for endocrine effects, the mechanism(s) of this regulation remain obscure at the cellular and molecular levels. One system that is amenable to establishing mechanistic links is the cutaneous immune system. In the skin, Langerhans cells (LCs), antigen presenting cells in the epidermis, are innervated. Furthermore, our laboratory has previously established that norepinephrine (NE), epinephrine (EPI) and three neuropeptides [calcitonin gene-related peptide (CGRP), pituitary adenylate activating polypeptide (PACAP), and vasoactive intestinal peptide (VIP)] are all able to modulate cutaneous immune responses in vivo and in vitro. This neuro-immunological interaction is probably important in (a) some pathological conditions (atopic dermatitis, psoriasis, autoimmune disorders), (b) the normal responses to invading pathogens and (c) the response to antigens during vaccination. Nevertheless, there are substantial gaps in understanding these pathways. It is not known which intracellular signaling pathway(s) are responsible for mediating the effects of neurotransmitters or if different neurotransmitters influence different pathways. Although nerves influence Th1 responses, it is not clear if they influence Th2 responses or the balance of Th1 to Th2 responses. We propose herein to test the hypothesis that neurotransmitters modulate both Th1- and Th2-dependent immune responses by modulating intracellular signaling pathways, especially the cAMP-dependent inhibition of NFkappaB activation. A correlate of this hypothesis is that the nervous system may have a role in selecting the type of immune response that occurs. This will be done in 3 specific aims: Aim 1 - To identify and study the intracellular signaling events that mediate the effects of NE/EPI, PACAP, VIP, and CGRP on the maturation of LCs. Aim 2 - To determine if neuro-peptides or neurotransmitters modulate the Th2 response, the Th1/Th2 cytokine balance and/or antibody production. Aim 3 - To determine if denervation influences the number of LCs, their maturation state or their capacity to induce contact hypersen-sitivity. By further exploring the types of cutaneous immune responses that are regulated by the nervous system and by determining the molecular mechanisms of this regulation, we will create the knowledge needed for rational design of drugs to modify cutaneous immune responses in pathological and normal. Immune responses in the skin.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Neurotransmitter Regulation of Immunity Through Effects on Endothelial Cells
-
批准号:8702657
-
项目类别:
-
资助金额:$22.37万
-
财政年份:2014
-
负责人:RICHARD David GRANSTEIN
-
依托单位:
Neurotransmitter Regulation of Immunity Through Effects on Endothelial Cells
-
批准号:8826027
-
项目类别:
-
资助金额:$18.65万
-
财政年份:2014
-
负责人:RICHARD David GRANSTEIN
-
依托单位:
Vaccine Development: Purinergic Agonists as Adjuvants
-
批准号:6754602
-
项目类别:
-
资助金额:$33.6万
-
财政年份:2004
-
负责人:RICHARD David GRANSTEIN
-
依托单位:
Vaccine Development: Purinergic Agonists as Adjuvants
-
批准号:6891607
-
项目类别:
-
资助金额:$33.6万
-
财政年份:2004
-
负责人:RICHARD David GRANSTEIN
-
依托单位:
SIXTH INTERNATIONAL WORKSHOP ON LANGERHANS CELLS
-
批准号:6033174
-
项目类别:
-
资助金额:$0.8万
-
财政年份:1999
-
负责人:RICHARD David GRANSTEIN
-
依托单位:
REGULATION OF LANGERHANS CELL FUNCTION
-
批准号:6055626
-
项目类别:
-
资助金额:$25.0万
-
财政年份:1997
-
负责人:RICHARD David GRANSTEIN
-
依托单位:
REGULATION OF LANGERHANS CELL FUNCTION
-
批准号:2769650
-
项目类别:
-
资助金额:$24.47万
-
财政年份:1997
-
负责人:RICHARD David GRANSTEIN
-
依托单位:
REGULATION OF LANGERHANS CELL FUNCTION
-
批准号:2646438
-
项目类别:
-
资助金额:$22.52万
-
财政年份:1997
-
负责人:RICHARD David GRANSTEIN
-
依托单位:
REGULATION OF LANGERHANS CELL FUNCTION BY CGRP
-
批准号:2081683
-
项目类别:
-
资助金额:$8.56万
-
财政年份:1994
-
负责人:RICHARD David GRANSTEIN
-
依托单位:
REGULATION OF LANGERHANS CELL FUNCTION BY CGRP
-
批准号:2081685
-
项目类别:
-
资助金额:$18.16万
-
财政年份:1994
-
负责人:RICHARD David GRANSTEIN
-
依托单位:
REGULATION OF LANGERHANS CELL FUNCTION BY CGRP
-
批准号:2081682
-
项目类别:
-
资助金额:$16.3万
-
财政年份:1994
-
负责人:RICHARD David GRANSTEIN
-
依托单位:
REGULATION OF LANGERHANS CELL FUNCTION BY CGRP
-
批准号:2081684
-
项目类别:
-
资助金额:$8.36万
-
财政年份:1994
-
负责人:RICHARD David GRANSTEIN
-
依托单位:
REGULATION OF LANGERHANS CELL FUNCTION BY CGRP
-
批准号:2457971
-
项目类别:
-
资助金额:$18.85万
-
财政年份:1994
-
负责人:RICHARD David GRANSTEIN
-
依托单位:
LANGERHANS CELLS AND NERVES: BIDIRECTIONAL SIGNALING
-
批准号:6534422
-
项目类别:
-
资助金额:$26.36万
-
财政年份:1992
-
负责人:RICHARD David GRANSTEIN
-
依托单位:
EPIDERMAL ANTIGEN-PRESENTING CELLS AND TUMOR IMMUNITY
-
批准号:2080189
-
项目类别:
-
资助金额:$18.61万
-
财政年份:1992
-
负责人:RICHARD David GRANSTEIN
-
依托单位:
EPIDERMAL ANTIGEN PRESENTING CELLS AND TUMOR IMMUNITY
-
批准号:3161100
-
项目类别:
-
资助金额:$17.05万
-
财政年份:1992
-
负责人:RICHARD David GRANSTEIN
-
依托单位:
EPIDERMAL ANTIGEN-PRESENTING CELLS AND TUMOR IMMUNITY
-
批准号:2080188
-
项目类别:
-
资助金额:$17.88万
-
财政年份:1992
-
负责人:RICHARD David GRANSTEIN
-
依托单位:
EPIDERMAL ANTIGEN-PRESENTING CELLS AND TUMOR IMMUNITY
-
批准号:2080187
-
项目类别:
-
资助金额:$16.79万
-
财政年份:1992
-
负责人:RICHARD David GRANSTEIN
-
依托单位:
Langerhans Cells and Nerves: Bidirectional Signaling
-
批准号:7628982
-
项目类别:
-
资助金额:$34.34万
-
财政年份:1992
-
负责人:RICHARD David GRANSTEIN
-
依托单位:
LANGERHANS CELLS AND NERVES: BIDIRECTIONAL SIGNALING
-
批准号:6651112
-
项目类别:
-
资助金额:$26.85万
-
财政年份:1992
-
负责人:RICHARD David GRANSTEIN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
全细胞疫苗Cell@MnO2的乳腺癌术后免疫响应监测与放射免疫治疗研究
-
批准号:QN25H220002
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:顾媛
-
依托单位:
染色体外环状DNA以cell-in-cell途径促进基因横向传递和扩增的研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:王锐智
-
依托单位:
GMFG/F-actin/cell adhesion 轴驱动 EHT 在造
血干细胞生成中的作用及机制研究
-
批准号:TGY24H080011
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:李鸿鹄
-
依托单位:
基于In-cell NMR策略对“舟楫之剂”桔梗中引经药效物质的快速发现研究
-
批准号:82305053
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:王丽明
-
依托单位:
面向Cell-Free网络的协同虚拟化与动态传输
-
批准号:62371367
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:陈健
-
依托单位:
Cell-in-cell促进曲妥珠单抗耐药乳腺癌细胞转移的作用与分子机制
-
批准号:82373069
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:何美芳
-
依托单位:
基于Multi-Pass Cell的高功率皮秒激光脉冲非线性压缩关键技术研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:宋贾俊
-
依托单位:
基于定点突变膜受体Cell-free合成生物色谱新方法的PDGFRβ抑制剂筛选和结合位点分析
-
批准号:82273886
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:原永芳
-
依托单位:
FLRT3抑制异质性cell-in-cell结构形成机制及细胞免疫调节作用研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:51万元
-
批准年份:2022
-
负责人:黄红艳
-
依托单位:
基于Cell-SELEX 的磁珠富集技术与LAMP 联合构建的梅毒螺旋体核酸检测方法及其临床应用
-
批准号:2021JJ30609
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:肖勇健
-
依托单位: